Characterization of T Antigens, Including Middle T and Alternative T, Expressed by the Human Polyomavirus Associated with Trichodysplasia Spinulosa

The polyomavirus tumor (T) antigens play crucial roles in viral replication, transcription, and cellular transformation. They are encoded by partially overlapping open reading frames (ORFs) located in the early region through alternative mRNA splicing. The T expression pattern of the trichodysplasia...

Full description

Saved in:
Bibliographic Details
Published inJournal of virology Vol. 89; no. 18; pp. 9427 - 9439
Main Authors van der Meijden, Els, Kazem, Siamaque, Dargel, Christina A., van Vuren, Nick, Hensbergen, Paul J., Feltkamp, Mariet C. W.
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 01.09.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The polyomavirus tumor (T) antigens play crucial roles in viral replication, transcription, and cellular transformation. They are encoded by partially overlapping open reading frames (ORFs) located in the early region through alternative mRNA splicing. The T expression pattern of the trichodysplasia spinulosa-associated polyomavirus (TSPyV) has not been established yet, hampering further study of its pathogenic mechanisms and taxonomic relationship. Here, we characterized TSPyV T antigen expression in human cell lines transfected with the TSPyV early region. Sequencing of T antigen-encoded reverse transcription-PCR (RT-PCR) products revealed three splice donor and acceptor sites creating six mRNA splice products that potentially encode the antigens small T (ST), middle T (MT), large T (LT), tiny T, 21kT, and alternative T (ALTO). Except for 21kT, these splice products were also detected in skin of TSPyV-infected patients. At least three splice products were confirmed by Northern blotting, likely encoding LT, MT, ST, 21kT, and ALTO. Protein expression was demonstrated for LT, ALTO, and possibly MT, with LT detected in the nucleus and ALTO in the cytoplasm of transfected cells. Splice site and start codon mutations indicated that ALTO is encoded by the same splice product that encodes LT and uses internal start codons for initiation. The genuineness of ALTO was indicated by the identification of acetylated N-terminal ALTO peptides by mass spectrometry. Summarizing, TSPyV exhibits an expression pattern characterized by both MT and ALTO expression, combining features of rodent and human polyomaviruses. This unique expression pattern provides important leads for further study of polyomavirus-related disease and for an understanding of polyomavirus evolution. IMPORTANCE The human trichodysplasia spinulosa-associated polyomavirus (TSPyV) is distinguished among polyomaviruses for combining productive infection with cell-transforming properties. In the research presented here, we further substantiate this unique position by indicating expression of both middle T antigen (MT) and alternative T antigen (ALTO) in TSPyV. So far, none of the human polyomaviruses was shown to express MT, which is considered the most important viral oncoprotein of rodent polyomaviruses. Coexpression of ALTO and MT, which involves a conserved, recently recognized overlapping ORF subject to positive selection, has not been observed before for any polyomavirus. As a result of our findings, this study provides valuable new insights into polyomavirus T gene use and expression. Obviously, these insights will be instrumental in further study and gaining an understanding of TSPyV pathogenicity. More importantly, however, they provide important leads with regard to the interrelationship, functionality, and evolution of polyomaviruses as a whole, indicating that TSPyV is a suitable model virus to study these entities further.
AbstractList UNLABELLEDThe polyomavirus tumor (T) antigens play crucial roles in viral replication, transcription, and cellular transformation. They are encoded by partially overlapping open reading frames (ORFs) located in the early region through alternative mRNA splicing. The T expression pattern of the trichodysplasia spinulosa-associated polyomavirus (TSPyV) has not been established yet, hampering further study of its pathogenic mechanisms and taxonomic relationship. Here, we characterized TSPyV T antigen expression in human cell lines transfected with the TSPyV early region. Sequencing of T antigen-encoded reverse transcription-PCR (RT-PCR) products revealed three splice donor and acceptor sites creating six mRNA splice products that potentially encode the antigens small T (ST), middle T (MT), large T (LT), tiny T, 21kT, and alternative T (ALTO). Except for 21kT, these splice products were also detected in skin of TSPyV-infected patients. At least three splice products were confirmed by Northern blotting, likely encoding LT, MT, ST, 21kT, and ALTO. Protein expression was demonstrated for LT, ALTO, and possibly MT, with LT detected in the nucleus and ALTO in the cytoplasm of transfected cells. Splice site and start codon mutations indicated that ALTO is encoded by the same splice product that encodes LT and uses internal start codons for initiation. The genuineness of ALTO was indicated by the identification of acetylated N-terminal ALTO peptides by mass spectrometry. Summarizing, TSPyV exhibits an expression pattern characterized by both MT and ALTO expression, combining features of rodent and human polyomaviruses. This unique expression pattern provides important leads for further study of polyomavirus-related disease and for an understanding of polyomavirus evolution.IMPORTANCEThe human trichodysplasia spinulosa-associated polyomavirus (TSPyV) is distinguished among polyomaviruses for combining productive infection with cell-transforming properties. In the research presented here, we further substantiate this unique position by indicating expression of both middle T antigen (MT) and alternative T antigen (ALTO) in TSPyV. So far, none of the human polyomaviruses was shown to express MT, which is considered the most important viral oncoprotein of rodent polyomaviruses. Coexpression of ALTO and MT, which involves a conserved, recently recognized overlapping ORF subject to positive selection, has not been observed before for any polyomavirus. As a result of our findings, this study provides valuable new insights into polyomavirus T gene use and expression. Obviously, these insights will be instrumental in further study and gaining an understanding of TSPyV pathogenicity. More importantly, however, they provide important leads with regard to the interrelationship, functionality, and evolution of polyomaviruses as a whole, indicating that TSPyV is a suitable model virus to study these entities further.
The polyomavirus tumor (T) antigens play crucial roles in viral replication, transcription, and cellular transformation. They are encoded by partially overlapping open reading frames (ORFs) located in the early region through alternative mRNA splicing. The T expression pattern of the trichodysplasia spinulosa-associated polyomavirus (TSPyV) has not been established yet, hampering further study of its pathogenic mechanisms and taxonomic relationship. Here, we characterized TSPyV T antigen expression in human cell lines transfected with the TSPyV early region. Sequencing of T antigen-encoded reverse transcription-PCR (RT-PCR) products revealed three splice donor and acceptor sites creating six mRNA splice products that potentially encode the antigens small T (ST), middle T (MT), large T (LT), tiny T, 21kT, and alternative T (ALTO). Except for 21kT, these splice products were also detected in skin of TSPyV-infected patients. At least three splice products were confirmed by Northern blotting, likely encoding LT, MT, ST, 21kT, and ALTO. Protein expression was demonstrated for LT, ALTO, and possibly MT, with LT detected in the nucleus and ALTO in the cytoplasm of transfected cells. Splice site and start codon mutations indicated that ALTO is encoded by the same splice product that encodes LT and uses internal start codons for initiation. The genuineness of ALTO was indicated by the identification of acetylated N-terminal ALTO peptides by mass spectrometry. Summarizing, TSPyV exhibits an expression pattern characterized by both MT and ALTO expression, combining features of rodent and human polyomaviruses. This unique expression pattern provides important leads for further study of polyomavirus-related disease and for an understanding of polyomavirus evolution. The human trichodysplasia spinulosa-associated polyomavirus (TSPyV) is distinguished among polyomaviruses for combining productive infection with cell-transforming properties. In the research presented here, we further substantiate this unique position by indicating expression of both middle T antigen (MT) and alternative T antigen (ALTO) in TSPyV. So far, none of the human polyomaviruses was shown to express MT, which is considered the most important viral oncoprotein of rodent polyomaviruses. Coexpression of ALTO and MT, which involves a conserved, recently recognized overlapping ORF subject to positive selection, has not been observed before for any polyomavirus. As a result of our findings, this study provides valuable new insights into polyomavirus T gene use and expression. Obviously, these insights will be instrumental in further study and gaining an understanding of TSPyV pathogenicity. More importantly, however, they provide important leads with regard to the interrelationship, functionality, and evolution of polyomaviruses as a whole, indicating that TSPyV is a suitable model virus to study these entities further.
The polyomavirus tumor (T) antigens play crucial roles in viral replication, transcription, and cellular transformation. They are encoded by partially overlapping open reading frames (ORFs) located in the early region through alternative mRNA splicing. The T expression pattern of the trichodysplasia spinulosa-associated polyomavirus (TSPyV) has not been established yet, hampering further study of its pathogenic mechanisms and taxonomic relationship. Here, we characterized TSPyV T antigen expression in human cell lines transfected with the TSPyV early region. Sequencing of T antigen-encoded reverse transcription-PCR (RT-PCR) products revealed three splice donor and acceptor sites creating six mRNA splice products that potentially encode the antigens small T (ST), middle T (MT), large T (LT), tiny T, 21kT, and alternative T (ALTO). Except for 21kT, these splice products were also detected in skin of TSPyV-infected patients. At least three splice products were confirmed by Northern blotting, likely encoding LT, MT, ST, 21kT, and ALTO. Protein expression was demonstrated for LT, ALTO, and possibly MT, with LT detected in the nucleus and ALTO in the cytoplasm of transfected cells. Splice site and start codon mutations indicated that ALTO is encoded by the same splice product that encodes LT and uses internal start codons for initiation. The genuineness of ALTO was indicated by the identification of acetylated N-terminal ALTO peptides by mass spectrometry. Summarizing, TSPyV exhibits an expression pattern characterized by both MT and ALTO expression, combining features of rodent and human polyomaviruses. This unique expression pattern provides important leads for further study of polyomavirus-related disease and for an understanding of polyomavirus evolution. IMPORTANCE The human trichodysplasia spinulosa-associated polyomavirus (TSPyV) is distinguished among polyomaviruses for combining productive infection with cell-transforming properties. In the research presented here, we further substantiate this unique position by indicating expression of both middle T antigen (MT) and alternative T antigen (ALTO) in TSPyV. So far, none of the human polyomaviruses was shown to express MT, which is considered the most important viral oncoprotein of rodent polyomaviruses. Coexpression of ALTO and MT, which involves a conserved, recently recognized overlapping ORF subject to positive selection, has not been observed before for any polyomavirus. As a result of our findings, this study provides valuable new insights into polyomavirus T gene use and expression. Obviously, these insights will be instrumental in further study and gaining an understanding of TSPyV pathogenicity. More importantly, however, they provide important leads with regard to the interrelationship, functionality, and evolution of polyomaviruses as a whole, indicating that TSPyV is a suitable model virus to study these entities further.
Author Kazem, Siamaque
Feltkamp, Mariet C. W.
Hensbergen, Paul J.
van Vuren, Nick
van der Meijden, Els
Dargel, Christina A.
Author_xml – sequence: 1
  givenname: Els
  surname: van der Meijden
  fullname: van der Meijden, Els
  organization: Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands
– sequence: 2
  givenname: Siamaque
  surname: Kazem
  fullname: Kazem, Siamaque
  organization: Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands
– sequence: 3
  givenname: Christina A.
  surname: Dargel
  fullname: Dargel, Christina A.
  organization: Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands
– sequence: 4
  givenname: Nick
  surname: van Vuren
  fullname: van Vuren, Nick
  organization: Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands
– sequence: 5
  givenname: Paul J.
  surname: Hensbergen
  fullname: Hensbergen, Paul J.
  organization: Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands
– sequence: 6
  givenname: Mariet C. W.
  surname: Feltkamp
  fullname: Feltkamp, Mariet C. W.
  organization: Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26136575$$D View this record in MEDLINE/PubMed
BookMark eNptkUFv0zAYhi00xLrBjTPykUMz_Dm221yQqmqwoiGQKIib5ThOY-TYwXYK5W_wh0m3MQHiZMnf877fJz1n6MQHbxB6CuQCgC5fvPm0uSCkAiiAP0AzINWy4BzYCZoRQmnBy-XnU3SW0hdCgDHBHqFTKqAUfMFn6Oe6U1HpbKL9obINHocWb_HKZ7szPs3xxms3Ntbv8FvbNM5MQ-UbvHJTxE-J_fQzx5ffh2hSMg2uDzh3Bl-NvfL4fXCH0Ku9jWPCq5SCtipP0DebO7yNVnehOaTBqWQV_jBYP7qQ1GP0sFUumSd37zn6-Opyu74qrt-93qxX14UulywXUNIWRE11VS4AuOK1MJo1gra8JDUhCiau4u1C1Lw01AC0hhuoFdOCNRUvz9HL295hrHvTaONzVE4O0fYqHmRQVv498baTu7CXjDNasmPB87uCGL6OJmXZ26SNc8qbMCYJCyIoEYIe0Wd_7rpf8tvEBMxvAR1DStG09wgQeRQtJ9HyRrSEI07_wbXNNwKnS637f-gX8ROuNA
CitedBy_id crossref_primary_10_1111_tid_12702
crossref_primary_10_3389_fmicb_2022_834368
crossref_primary_10_1002_rmv_2220
crossref_primary_10_1111_jdv_14326
crossref_primary_10_3390_v11100930
crossref_primary_10_1016_j_meegid_2023_105439
crossref_primary_10_1016_j_meegid_2017_06_011
crossref_primary_10_1016_j_vetmic_2017_01_005
crossref_primary_10_1016_j_piel_2017_05_001
crossref_primary_10_1371_journal_ppat_1005574
crossref_primary_10_1099_jgv_0_000714
crossref_primary_10_1371_journal_pone_0244334
crossref_primary_10_1128_JVI_01008_16
crossref_primary_10_1146_annurev_virology_110615_042226
crossref_primary_10_3390_v15112235
crossref_primary_10_3390_v12091014
crossref_primary_10_1099_jgv_0_001467
crossref_primary_10_1177_1178122X17744785
crossref_primary_10_1111_bjd_17592
crossref_primary_10_3390_v8100292
crossref_primary_10_1016_j_virol_2017_03_007
crossref_primary_10_1007_s13205_020_02583_w
crossref_primary_10_1073_pnas_2316467120
crossref_primary_10_6061_clinics_2018_e558s
crossref_primary_10_7883_yoken_JJID_2019_391
crossref_primary_10_1016_j_jcv_2016_01_001
crossref_primary_10_1111_bjd_14239
crossref_primary_10_1111_tid_13434
crossref_primary_10_1016_j_virol_2015_09_013
crossref_primary_10_1002_jcp_27715
crossref_primary_10_1016_j_jid_2018_09_013
crossref_primary_10_1371_journal_ppat_1009582
crossref_primary_10_3389_fmicb_2018_00398
Cites_doi 10.1002/ijc.29200
10.1016/S0065-230X(10)06001-X
10.1128/MMBR.66.2.179-202.2002
10.1073/pnas.0806526105
10.1128/JVI.01336-09
10.1056/NEJMoa020439
10.1002/j.1460-2075.1993.tb06162.x
10.1128/jvi.71.8.6068-6074.1997
10.1093/nar/15.20.8125
10.1007/s00705-011-1008-x
10.1093/nar/gkv378
10.1128/MMBR.00009-09
10.1016/j.semcancer.2009.03.002
10.1371/journal.ppat.1000363
10.1128/JVI.02400-09
10.1128/jvi.65.6.3301-3308.1991
10.1038/nrmicro2992
10.1093/jnci/djp332
10.1001/jamadermatol.2014.1095
10.1128/JVI.00517-06
10.1093/nar/gkp215
10.1016/0092-8674(78)90083-1
10.1038/nrmicro2984
10.1111/jdv.13111
10.1128/CMR.05031-11
10.1371/journal.ppat.1001024
10.1099/vir.0.048462-0
10.1097/JTO.0000000000000390
10.1021/pr3005937
10.1371/journal.pone.0108947
10.3109/13550289509113966
10.1093/infdis/jiu250
10.1099/vir.0.83317-0
10.1016/j.jcv.2011.11.007
10.1099/vir.0.009159-0
10.1073/pnas.1303526110
10.1128/CVI.00438-12
10.1126/science.1152586
10.1371/journal.pone.0081078
10.1038/nrc946
10.1001/jamadermatol.2014.1116
10.1093/infdis/jiu524
10.1172/JCI46323
ContentType Journal Article
Copyright Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Copyright © 2015, American Society for Microbiology. All Rights Reserved. 2015 American Society for Microbiology
Copyright_xml – notice: Copyright © 2015, American Society for Microbiology. All Rights Reserved.
– notice: Copyright © 2015, American Society for Microbiology. All Rights Reserved. 2015 American Society for Microbiology
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1128/JVI.00911-15
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Characterization of TSPyV T Antigens
EISSN 1098-5514
EndPage 9439
ExternalDocumentID PMC4542345
26136575
10_1128_JVI_00911_15
Genre Journal Article
GroupedDBID ---
-~X
0R~
18M
29L
2WC
39C
4.4
53G
5GY
5RE
5VS
85S
AAFWJ
AAGFI
AAYXX
ABPPZ
ACGFO
ACNCT
ADBBV
AENEX
AGVNZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CITATION
CS3
DIK
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HYE
HZ~
IH2
KQ8
N9A
O9-
OK1
P2P
RHI
RNS
RPM
RSF
TR2
UPT
W2D
W8F
WH7
WOQ
YQT
~02
~KM
.55
.GJ
3O-
41~
6TJ
AAYJJ
ADXHL
AFFNX
AI.
C1A
CGR
CUY
CVF
D0S
ECM
EIF
MVM
NPM
OHT
VH1
X7M
Y6R
ZGI
ZXP
7X8
5PM
ID FETCH-LOGICAL-c384t-132f16b2c937115a5b6ec4d62f530b00a1c3895f76b53e2e11fe5e1ba4c64d953
ISSN 0022-538X
IngestDate Thu Aug 21 18:27:28 EDT 2025
Fri Jul 11 01:45:40 EDT 2025
Mon Jul 21 06:03:47 EDT 2025
Thu Apr 24 23:05:42 EDT 2025
Tue Jul 01 01:02:39 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 18
Language English
License Copyright © 2015, American Society for Microbiology. All Rights Reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c384t-132f16b2c937115a5b6ec4d62f530b00a1c3895f76b53e2e11fe5e1ba4c64d953
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Citation van der Meijden E, Kazem S, Dargel CA, van Vuren N, Hensbergen PJ, Feltkamp MCW. 2015. Characterization of T antigens, including middle T and alternative T, expressed by the human polyomavirus associated with trichodysplasia spinulosa. J Virol 89:9427–9439. doi:10.1128/JVI.00911-15.
OpenAccessLink https://jvi.asm.org/content/jvi/89/18/9427.full.pdf
PMID 26136575
PQID 1706206625
PQPubID 23479
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4542345
proquest_miscellaneous_1706206625
pubmed_primary_26136575
crossref_primary_10_1128_JVI_00911_15
crossref_citationtrail_10_1128_JVI_00911_15
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-09-01
PublicationDateYYYYMMDD 2015-09-01
PublicationDate_xml – month: 09
  year: 2015
  text: 2015-09-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Journal of virology
PublicationTitleAlternate J Virol
PublicationYear 2015
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_41_2
e_1_3_2_40_2
e_1_3_2_20_2
e_1_3_2_43_2
e_1_3_2_21_2
e_1_3_2_42_2
e_1_3_2_22_2
e_1_3_2_45_2
e_1_3_2_23_2
e_1_3_2_44_2
e_1_3_2_24_2
e_1_3_2_25_2
Kazem S (e_1_3_2_35_2) 2013; 19
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_2_2
e_1_3_2_14_2
19759150 - J Virol. 2009 Dec;83(23):12118-28
12040123 - Microbiol Mol Biol Rev. 2002 Jun;66(2):179-202
25291363 - PLoS One. 2014;9(10):e108947
20444890 - J Virol. 2010 Jul;84(14):7064-72
21562881 - Arch Virol. 2011 Sep;156(9):1627-34
25231015 - J Infect Dis. 2015 May 15;211(10):1560-5
23474680 - Nat Rev Microbiol. 2013 Apr;11(4):264-76
8223482 - EMBO J. 1993 Dec;12(12):4739-46
24943872 - JAMA Dermatol. 2014 Nov;150(11):1180-6
24795478 - J Infect Dis. 2014 Nov 15;210(10):1595-9
21841310 - J Clin Invest. 2011 Sep;121(9):3623-34
19776382 - J Natl Cancer Inst. 2009 Nov 4;101(21):1510-22
25526237 - J Thorac Oncol. 2015 Feb;10(2):360-6
23474685 - Nat Rev Microbiol. 2013 Apr;11(4):239-51
18202256 - Science. 2008 Feb 22;319(5866):1096-100
23302741 - Clin Vaccine Immunol. 2013 Mar;20(3):363-8
19264611 - J Gen Virol. 2009 May;90(Pt 5):1238-45
22196870 - J Clin Virol. 2012 Mar;53(3):225-30
3313277 - Nucleic Acids Res. 1987 Oct 26;15(20):8125-48
20686659 - PLoS Pathog. 2010;6(7):e1001024
20399955 - Adv Cancer Res. 2010;106:1-51
9223500 - J Virol. 1997 Aug;71(8):6068-74
24278381 - PLoS One. 2013;8(11):e81078
18753241 - J Gen Virol. 2008 Sep;89(Pt 9):2303-14
9222358 - J Neurovirol. 1995 Jun;1(2):195-206
25208506 - Int J Cancer. 2015 Mar 1;136(5):E290-300
19325891 - PLoS Pathog. 2009 Mar;5(3):e1000363
12181403 - N Engl J Med. 2002 Aug 15;347(7):488-96
25389794 - JAMA Dermatol. 2014 Nov;150(11):1234-6
23847207 - Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12744-9
19505649 - Semin Cancer Biol. 2009 Aug;19(4):218-28
25904630 - Nucleic Acids Res. 2015 May 26;43(10):4800-13
12459733 - Nat Rev Cancer. 2002 Dec;2(12):951-6
25766099 - J Eur Acad Dermatol Venereol. 2016 Jun;30(6):1061-2
22763635 - Clin Microbiol Rev. 2012 Jul;25(3):471-506
18812503 - Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16272-7
1709702 - J Virol. 1991 Jun;65(6):3301-8
212199 - Cell. 1978 Sep;15(1):65-77
19339519 - Nucleic Acids Res. 2009 May;37(9):e67
19721090 - Microbiol Mol Biol Rev. 2009 Sep;73(3):542-63, Table of Contents
23050552 - J Proteome Res. 2012 Dec 7;11(12):5804-14
23255626 - J Gen Virol. 2013 Mar;94(Pt 3):482-96
16775341 - J Virol. 2006 Jul;80(13):6553-8
References_xml – ident: e_1_3_2_24_2
  doi: 10.1002/ijc.29200
– ident: e_1_3_2_18_2
  doi: 10.1016/S0065-230X(10)06001-X
– ident: e_1_3_2_19_2
  doi: 10.1128/MMBR.66.2.179-202.2002
– ident: e_1_3_2_32_2
  doi: 10.1073/pnas.0806526105
– ident: e_1_3_2_26_2
  doi: 10.1128/JVI.01336-09
– ident: e_1_3_2_9_2
  doi: 10.1056/NEJMoa020439
– ident: e_1_3_2_34_2
  doi: 10.1002/j.1460-2075.1993.tb06162.x
– ident: e_1_3_2_31_2
  doi: 10.1128/jvi.71.8.6068-6074.1997
– volume: 19
  start-page: 298
  year: 2013
  ident: e_1_3_2_35_2
  article-title: Global circulation of slowly evolving trichodysplasia spinulosa-associated polyomavirus and its adaptation to the human population through alternative T antigens
  publication-title: J Neurovirol
– ident: e_1_3_2_45_2
  doi: 10.1093/nar/15.20.8125
– ident: e_1_3_2_17_2
  doi: 10.1007/s00705-011-1008-x
– ident: e_1_3_2_36_2
  doi: 10.1093/nar/gkv378
– ident: e_1_3_2_23_2
  doi: 10.1128/MMBR.00009-09
– ident: e_1_3_2_20_2
  doi: 10.1016/j.semcancer.2009.03.002
– ident: e_1_3_2_5_2
  doi: 10.1371/journal.ppat.1000363
– ident: e_1_3_2_25_2
  doi: 10.1128/JVI.02400-09
– ident: e_1_3_2_37_2
  doi: 10.1128/jvi.65.6.3301-3308.1991
– ident: e_1_3_2_3_2
  doi: 10.1038/nrmicro2992
– ident: e_1_3_2_2_2
  doi: 10.1093/jnci/djp332
– ident: e_1_3_2_28_2
  doi: 10.1001/jamadermatol.2014.1095
– ident: e_1_3_2_43_2
  doi: 10.1128/JVI.00517-06
– ident: e_1_3_2_42_2
  doi: 10.1093/nar/gkp215
– ident: e_1_3_2_38_2
  doi: 10.1016/0092-8674(78)90083-1
– ident: e_1_3_2_44_2
  doi: 10.1038/nrmicro2984
– ident: e_1_3_2_29_2
  doi: 10.1111/jdv.13111
– ident: e_1_3_2_8_2
  doi: 10.1128/CMR.05031-11
– ident: e_1_3_2_11_2
  doi: 10.1371/journal.ppat.1001024
– ident: e_1_3_2_4_2
  doi: 10.1099/vir.0.048462-0
– ident: e_1_3_2_15_2
  doi: 10.1097/JTO.0000000000000390
– ident: e_1_3_2_41_2
  doi: 10.1021/pr3005937
– ident: e_1_3_2_27_2
  doi: 10.1371/journal.pone.0108947
– ident: e_1_3_2_33_2
  doi: 10.3109/13550289509113966
– ident: e_1_3_2_16_2
  doi: 10.1093/infdis/jiu250
– ident: e_1_3_2_40_2
  doi: 10.1099/vir.0.83317-0
– ident: e_1_3_2_12_2
  doi: 10.1016/j.jcv.2011.11.007
– ident: e_1_3_2_30_2
  doi: 10.1099/vir.0.009159-0
– ident: e_1_3_2_39_2
  doi: 10.1073/pnas.1303526110
– ident: e_1_3_2_7_2
  doi: 10.1128/CVI.00438-12
– ident: e_1_3_2_10_2
  doi: 10.1126/science.1152586
– ident: e_1_3_2_6_2
  doi: 10.1371/journal.pone.0081078
– ident: e_1_3_2_22_2
  doi: 10.1038/nrc946
– ident: e_1_3_2_13_2
  doi: 10.1001/jamadermatol.2014.1116
– ident: e_1_3_2_14_2
  doi: 10.1093/infdis/jiu524
– ident: e_1_3_2_21_2
  doi: 10.1172/JCI46323
– reference: 23847207 - Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12744-9
– reference: 19339519 - Nucleic Acids Res. 2009 May;37(9):e67
– reference: 23255626 - J Gen Virol. 2013 Mar;94(Pt 3):482-96
– reference: 23302741 - Clin Vaccine Immunol. 2013 Mar;20(3):363-8
– reference: 12459733 - Nat Rev Cancer. 2002 Dec;2(12):951-6
– reference: 18753241 - J Gen Virol. 2008 Sep;89(Pt 9):2303-14
– reference: 12040123 - Microbiol Mol Biol Rev. 2002 Jun;66(2):179-202
– reference: 18202256 - Science. 2008 Feb 22;319(5866):1096-100
– reference: 24943872 - JAMA Dermatol. 2014 Nov;150(11):1180-6
– reference: 20399955 - Adv Cancer Res. 2010;106:1-51
– reference: 23474680 - Nat Rev Microbiol. 2013 Apr;11(4):264-76
– reference: 25291363 - PLoS One. 2014;9(10):e108947
– reference: 25904630 - Nucleic Acids Res. 2015 May 26;43(10):4800-13
– reference: 212199 - Cell. 1978 Sep;15(1):65-77
– reference: 8223482 - EMBO J. 1993 Dec;12(12):4739-46
– reference: 20686659 - PLoS Pathog. 2010;6(7):e1001024
– reference: 20444890 - J Virol. 2010 Jul;84(14):7064-72
– reference: 24278381 - PLoS One. 2013;8(11):e81078
– reference: 18812503 - Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16272-7
– reference: 19264611 - J Gen Virol. 2009 May;90(Pt 5):1238-45
– reference: 1709702 - J Virol. 1991 Jun;65(6):3301-8
– reference: 12181403 - N Engl J Med. 2002 Aug 15;347(7):488-96
– reference: 25766099 - J Eur Acad Dermatol Venereol. 2016 Jun;30(6):1061-2
– reference: 19505649 - Semin Cancer Biol. 2009 Aug;19(4):218-28
– reference: 16775341 - J Virol. 2006 Jul;80(13):6553-8
– reference: 25208506 - Int J Cancer. 2015 Mar 1;136(5):E290-300
– reference: 25231015 - J Infect Dis. 2015 May 15;211(10):1560-5
– reference: 9223500 - J Virol. 1997 Aug;71(8):6068-74
– reference: 22763635 - Clin Microbiol Rev. 2012 Jul;25(3):471-506
– reference: 9222358 - J Neurovirol. 1995 Jun;1(2):195-206
– reference: 25526237 - J Thorac Oncol. 2015 Feb;10(2):360-6
– reference: 3313277 - Nucleic Acids Res. 1987 Oct 26;15(20):8125-48
– reference: 19776382 - J Natl Cancer Inst. 2009 Nov 4;101(21):1510-22
– reference: 24795478 - J Infect Dis. 2014 Nov 15;210(10):1595-9
– reference: 21562881 - Arch Virol. 2011 Sep;156(9):1627-34
– reference: 19721090 - Microbiol Mol Biol Rev. 2009 Sep;73(3):542-63, Table of Contents
– reference: 25389794 - JAMA Dermatol. 2014 Nov;150(11):1234-6
– reference: 19759150 - J Virol. 2009 Dec;83(23):12118-28
– reference: 23474685 - Nat Rev Microbiol. 2013 Apr;11(4):239-51
– reference: 21841310 - J Clin Invest. 2011 Sep;121(9):3623-34
– reference: 23050552 - J Proteome Res. 2012 Dec 7;11(12):5804-14
– reference: 22196870 - J Clin Virol. 2012 Mar;53(3):225-30
– reference: 19325891 - PLoS Pathog. 2009 Mar;5(3):e1000363
SSID ssj0014464
Score 2.337937
Snippet The polyomavirus tumor (T) antigens play crucial roles in viral replication, transcription, and cellular transformation. They are encoded by partially...
UNLABELLEDThe polyomavirus tumor (T) antigens play crucial roles in viral replication, transcription, and cellular transformation. They are encoded by...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 9427
SubjectTerms Alternative Splicing - physiology
Antigens, Viral, Tumor - biosynthesis
Antigens, Viral, Tumor - genetics
Gene Expression Regulation, Viral - physiology
Genome and Regulation of Viral Gene Expression
HEK293 Cells
HeLa Cells
Humans
Polyomavirus - genetics
Polyomavirus - metabolism
Title Characterization of T Antigens, Including Middle T and Alternative T, Expressed by the Human Polyomavirus Associated with Trichodysplasia Spinulosa
URI https://www.ncbi.nlm.nih.gov/pubmed/26136575
https://www.proquest.com/docview/1706206625
https://pubmed.ncbi.nlm.nih.gov/PMC4542345
Volume 89
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb5swELeiTpP2Mu3_un_ypO0ppSvGhuQx6jq1nVJNKq3yhjAxLROFKAnVkq-xr7UPtTsbHJK2UrcXFGFjktyPu_Nx9ztCPiUx88Hq7jkJc7nDVTB2-uMUsywEV0r5PNWMN8MT__CMH4_EqNP508paquZyN1neWlfyP1KFcyBXrJL9B8naReEEfAb5whEkDMd7yXjfsi0vrecXIh8AUmw2j39e6bqVoY5EwDBGygd5HQe8hjNaHf7SCbG1OwrQMcH9H2W-KK_i62xazawkm4T1EFToZTlezCa6FLN7OsmKKi9n8R0OL1bUtWP4WDmFTBZDlf2std9Bvnq3FC-VxuppFl_FJjW8ialfmNQCQ4yQFXF3sNte9LyamuVOGsr_OqzhCpu31S4zAG08MobKaGckP0UXr62-TQeiBqa9ljLuc0M7UBv2Pje0STeNBsNCiOPzo11wODHDT6yMY5MQsGEzbSaj3kOxXgRXR_rqCBkPHjDYtGA_ja9H3-07Ldh484a7Hn9YU4bBel_a9153kG7sejaTd1veUPiEPK6lSgcGk09JRxXPyEPT2HTxnPzeRCYtUxrSBpk71OKSGlzCIOCStnBJwx1qUUnlggIqqUYlbaOSrlBJEZV0A5XUovIFOft2EO4fOnX7DyfxenzuuB5LXV-yBCkbXREL6auEj32WCm8PrEXswry-SANfCk8x5bqpEsqVMU98Pu4L7yXZKspCvSZUBBL73QcplwFPXCljCdsAz1NjmXhBL90m3eY_j5KaGx9btOTRbfLdJp_t7InhhLlj3sdGfBEobXwTFxeqrGYRclZhHwUGc14ZcdqVmI-ZpwGMBGuCthOQEH59pMguNTE8F7A54uLNPb_fW_Jo9eS9I1vzaaXeg4s9lx80cv8Cj5rWEg
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+of+T+Antigens%2C+Including+Middle+T+and+Alternative+T%2C+Expressed+by+the+Human+Polyomavirus+Associated+with+Trichodysplasia+Spinulosa&rft.jtitle=Journal+of+virology&rft.au=van+der+Meijden%2C+Els&rft.au=Kazem%2C+Siamaque&rft.au=Dargel%2C+Christina+A.&rft.au=van+Vuren%2C+Nick&rft.date=2015-09-01&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=89&rft.issue=18&rft.spage=9427&rft.epage=9439&rft_id=info:doi/10.1128%2FJVI.00911-15&rft.externalDBID=n%2Fa&rft.externalDocID=10_1128_JVI_00911_15
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon